How much funding has Immorna raised?

Immorna has raised $63.8M in total funding, most recently a Grant round.

Who are Immorna's investors?

Immorna's investors include Bill & Melinda Gates Foundation, RTW Investments, Qatar Investment Authority, China Growth Capital, Cowin Ventures, Qiming VP.

Where is Immorna headquartered?

Immorna is headquartered in Morrisville, North Carolina, United States.

What industry is Immorna in?

Immorna operates in Biotech, Healthcare.

Immorna

嘉晨西海（杭州）生物技术有限公司

Morrisville, United States · Founded 2019 · $63.8M raised

Biotech

Healthcare

Headquarters: Morrisville, North Carolina
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: immorna.com
Total Funding: $63.8M
Last Round: $3.8M GrantAug 2024
Rounds: 4

About

Immorna Biotherapeutics is a clinical-stage biotechnology company founded in 2019, focused on developing next-generation RNA-based therapeutics and vaccines utilizing conventional, self-replicating, and circular mRNA platforms. The company's pipeline spans tumor immunotherapy, infectious disease vaccines, rare diseases, and medical cosmetology, with lead program JCXH-213 targeting CD19. Headquartered in Morrisville, North Carolina, with operations also in Hangzhou, China, Immorna serves patients and healthcare systems globally through its proprietary CMC and delivery systems.

Summary

Immorna is a Biotech company based in Morrisville, United States, founded in 2019. It has raised $63.8M in total across 4 rounds, most recently a $3.8M Grant round in Aug 2024. Investors include Bill & Melinda Gates Foundation, RTW Investments and Qatar Investment Authority.